Release Date: 11/09/09 12:58 Summary: MUE Despatch of 2009 Annual Report Price Sensitive: No Download Document 5.84MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%